Axel Mark
3624
Renascience
4889
Ecomott
3987
Festaria Holdings
2736
Tecnisco
2962
(FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -2.31%92.33B | 0.15%22.72B | -2.36%24.33B | -8.24%22.68B | 1.86%22.6B | 24.20%94.51B | 13.18%22.69B | 26.50%24.92B | 30.88%24.71B | 27.05%22.18B |
Cost of revenue | -1.18%74.41B | -3.69%18.17B | -3.77%19.3B | -5.18%18.46B | 9.27%18.49B | 29.57%75.3B | 17.24%18.87B | 34.87%20.05B | 38.37%19.46B | 29.25%16.92B |
Gross profit | -6.71%17.92B | 19.08%4.56B | 3.43%5.04B | -19.64%4.22B | -21.95%4.11B | 6.86%19.21B | -3.33%3.83B | 0.77%4.87B | 9.02%5.25B | 20.44%5.26B |
Operating expense | 3.59%18.13B | -0.48%4.57B | 0.65%4.63B | 1.46%4.46B | 14.20%4.48B | 18.84%17.5B | 24.26%4.59B | 21.13%4.6B | 19.66%4.39B | 9.95%3.92B |
Staff costs | 4.15%6.47B | ---- | ---- | ---- | ---- | 20.06%6.22B | ---- | ---- | ---- | ---- |
Selling and administrative expenses | -9.00%3.92B | ---- | ---- | ---- | 14.20%4.48B | 12.29%4.31B | ---- | ---- | ---- | 9.95%3.92B |
-Selling and marketing expense | -9.00%3.92B | ---- | ---- | ---- | ---- | 12.29%4.31B | ---- | ---- | ---- | ---- |
-General and administrative expense | ---- | ---- | ---- | ---- | 14.20%4.48B | ---- | ---- | ---- | ---- | 9.95%3.92B |
Research and development costs | -0.88%2.71B | ---- | ---- | ---- | ---- | 7.65%2.73B | ---- | ---- | ---- | ---- |
Depreciation and amortization | 23.44%553M | ---- | ---- | ---- | ---- | 45.77%448M | ---- | ---- | ---- | ---- |
-Depreciation | 23.44%553M | ---- | ---- | ---- | ---- | 45.77%448M | ---- | ---- | ---- | ---- |
Other operating expenses | 17.86%4.47B | ---- | ---- | ---- | ---- | 32.44%3.8B | ---- | ---- | ---- | ---- |
Operating profit | -112.23%-209M | 97.92%-16M | 49.28%415M | -127.47%-236M | -127.76%-372M | -47.43%1.71B | -394.85%-768M | -73.33%278M | -25.06%859M | 67.10%1.34B |
Net non-operating interest income (expenses) | -10.00%-363M | -25.47%-133M | -36.46%-131M | 0.00%-74M | 53.70%-25M | -41.69%-330M | -77.62%-106M | -64.11%-96M | -29.92%-74M | 6.52%-54M |
Non-operating interest income | 129.79%216M | -114.89%-7M | 336.84%83M | 583.33%82M | 262.50%58M | 135.53%94M | 255.79%47M | 85.80%19M | 38.01%12M | 105.68%16M |
Non-operating interest expense | 36.56%579M | -17.65%126M | 86.09%214M | 81.40%156M | 18.57%83M | 55.42%424M | 109.91%153M | 67.34%115M | 30.99%86M | 6.80%70M |
Net investment income | -251.85%-380M | -17.31%-305M | 0 | -304.00%-51M | -151.06%-24M | -176.65%-108M | -1,002.25%-260M | 32.71%80M | 139.48%25M | -59.17%47M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 0.00%193M | 0 | -52.12%113M | 0 | 290.48%80M | 193M | 0 | 236M | -1M | -42M |
Income from associates and other participating interests | -81.77%190M | -190.21%-212M | -17.03%151M | -70.81%94M | -48.18%157M | 256.51%1.04B | 139.52%235M | 85.77%182M | 1,333.67%322M | 147.76%303M |
Special income (charges) | 54.65%-190M | 62.53%-157M | -13M | 14.87%-419M | -419M | 0 | ||||
Less:Restructuring and mergern&acquisition | --0 | ---- | ---- | ---- | ---- | ---186M | ---- | ---- | ---- | ---- |
Less:Other special charges | -89.26%65M | --32M | --13M | ---- | ---- | 1,038.05%605M | ---- | ---- | ---- | ---- |
Less:Write off | --125M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Other non-operating income (expenses) | 112.50%510M | 450.00%220M | -61.85%66M | 804.55%199M | 400.00%25M | 567.50%240M | 186.19%40M | 438.99%173M | 109.11%22M | -87.42%5M |
Income before tax | -110.80%-251M | 52.80%-606M | -29.74%600M | -107.55%-87M | -109.88%-158M | -22.44%2.32B | -508.96%-1.28B | -27.27%854M | 14.12%1.15B | 56.66%1.6B |
Income tax | -38.44%639M | 254.82%353M | 8.53%229M | -77.24%104M | -107.86%-47M | 17.67%1.04B | -802.15%-228M | -33.93%211M | 50.93%457M | 109.66%598M |
Net income | -169.39%-891M | 9.27%-959M | -42.55%370M | -127.63%-192M | -110.98%-110M | -39.23%1.28B | -469.57%-1.06B | -24.66%644M | -1.77%695M | 36.13%1B |
Net income continuous operations | -169.26%-890M | 9.19%-959M | -42.30%371M | -127.44%-191M | -111.08%-111M | -39.18%1.29B | -469.03%-1.06B | -24.78%643M | -1.63%696M | 36.13%1B |
Noncontrolling interests | -32.16%270M | 123.81%94M | -51.33%73M | -23.23%76M | -74.77%27M | 8.57%398M | -20.82%42M | 21.98%150M | -11.12%99M | 35.13%107M |
Net income attributable to the company | -231.19%-1.16B | 4.19%-1.05B | -39.55%298M | -144.97%-268M | -115.42%-138M | -49.32%885M | -360.56%-1.1B | -32.64%493M | -0.02%596M | 36.25%895M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -231.19%-1.16B | 4.19%-1.05B | -39.55%298M | -144.97%-268M | -115.42%-138M | -49.32%885M | -360.56%-1.1B | -32.64%493M | -0.02%596M | 36.25%895M |
Gross dividend payment | ||||||||||
Basic earnings per share | -234.12%-47.96 | 0.96%-43.49 | -38.86%12.32 | -146.22%-11.07 | -116.08%-5.72 | -48.49%35.76 | -362.70%-43.91 | -30.71%20.15 | 1.10%23.95 | 36.07%35.57 |
Diluted earnings per share | -234.12%-47.96 | 4.23%-43.49 | -38.74%12.297 | -146.24%-11.0733 | -116.08%-5.72 | -48.49%35.76 | -378.49%-45.4088 | -30.97%20.0741 | 1.10%23.95 | 36.07%35.57 |
Dividend per share | 10.53%42 | 10.53%21 | 0 | 10.53%21 | 0 | 0.00%38 | 0.00%19 | 0 | 0.00%19 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |